BeOne Medicines (ONC) News Today $306.05 +8.09 (+2.72%) As of 08/29/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ONC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period BeOne Medicines (NASDAQ:ONC) Shares Gap Up - Here's WhyAugust 31 at 11:44 AM | marketbeat.comAnalysts Set BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Price Target at $330.89August 30 at 2:01 AM | americanbankingnews.comBeOne Medicines stock rises after positive Phase 1/2 resultsAugust 30 at 2:43 AM | za.investing.comBeOne Medicines stock rises after positive Phase 1/2 resultsAugust 30 at 2:43 AM | in.investing.comBeOne Medicines succeeds in Phase 1/2 study for lymphoma therapyAugust 30 at 2:43 AM | msn.comBeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)August 29 at 6:00 AM | businesswire.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Average Recommendation of "Buy" from AnalystsAugust 29 at 3:32 AM | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Average Rating of "Buy" from AnalystsAugust 29 at 3:32 AM | marketbeat.comBeOne Medicines announces EC approved Tevimbra to treat NSCLCAugust 28, 2025 | msn.comWith 42% institutional ownership, BeOne Medicines Ltd. (NASDAQ:ONC) is a favorite amongst the big gunsAugust 28, 2025 | finance.yahoo.comBeOne Medicines shares dip after EU greenlights TEVIMBRA for lung cancerAugust 27, 2025 | msn.comBeOne to Present at the Morgan Stanley 23rd Annual Global Healthcare ConferenceAugust 26, 2025 | businesswire.comBeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-UpAugust 25, 2025 | finance.yahoo.comRoyalty Pharma confirms acquisition of royalty interest in Amgen’s ImdelltraAugust 25, 2025 | msn.comBeOne Medicines to sell royalty rights of Imdelltra to Royalty Pharma for $950MAugust 25, 2025 | msn.comBRUKINSA Tablet Approval Could Be a Game Changer for BeOne Medicines (ONC)August 22, 2025 | finance.yahoo.comBeOne Medicines’ Brukinsa tablet formulation approved by European CommissionAugust 21, 2025 | msn.comEuropean Commission Approves Tablet Formulation of BeOne Medicines' BRUKINSA® for All Approved IndicationsAugust 21, 2025 | businesswire.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Sells $3,308,855.85 in StockAugust 17, 2025 | marketbeat.comXiaobin Wu Sells 39,936 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockAugust 17, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) COO Xiaobin Wu Sells 49,858 SharesAugust 17, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Reaches New 12-Month High - Time to Buy?August 17, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Sells 11,013 Shares of StockAugust 16, 2025 | insidertrades.comThis Medical Stock With Blockbuster Cancer Drug Clears Entry Amid 923% Earnings GrowthAugust 15, 2025 | investors.comStock Market Today: Dow Jones Index Rises While Nvidia-Backed CoreWeave Sinks On Earnings (Live Coverage)August 13, 2025 | msn.comBeOne Medicines (NASDAQ:ONC) Upgraded to Strong-Buy at Wall Street ZenAugust 10, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Shares Gap Down - What's Next?August 9, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Releases Earnings Results, Beats Expectations By $0.36 EPSAugust 9, 2025 | marketbeat.comRoyal Bank Of Canada Issues Positive Forecast for BeOne Medicines (NASDAQ:ONC) Stock PriceAugust 8, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Stock Price Expected to Rise, Guggenheim Analyst SaysAugust 8, 2025 | marketbeat.comBeOne Medicines Ltd. (NASDAQ:ONC) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CFO Sells 1,190 Shares of StockAugust 6, 2025 | marketbeat.comBeOne Medicines outlines $5B–$5.3B 2025 revenue target as BRUKINSA leads BTK market and global expansion acceleratesAugust 6, 2025 | msn.comBeOne Medicines (NASDAQ:ONC) Hits New 52-Week High - Here's WhyAugust 6, 2025 | marketbeat.comBeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comBeOne Medicines Ltd. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Given Consensus Recommendation of "Buy" by BrokeragesAugust 3, 2025 | marketbeat.comLai Wang Sells 259 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockAugust 1, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Sells 920 Shares of StockAugust 1, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 4,041 SharesAugust 1, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 259 SharesAugust 1, 2025 | insidertrades.comBeOne Medicines (NASDAQ:ONC) Reaches New 12-Month High - Here's WhyJuly 30, 2025 | marketbeat.comBeOne Medicines' Tevimbra Gets CHMP Positive OpinionJuly 28, 2025 | marketwatch.comBeOne Medicines shares climb following positive EU backing for lung cancer therapyJuly 28, 2025 | msn.comBeOne Medicines Ltd.: BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA in Neoadjuvant/Adjuvant NSCLC TreatmentJuly 28, 2025 | finanznachrichten.deWall Street Zen Upgrades BeOne Medicines (NASDAQ:ONC) to BuyJuly 26, 2025 | marketbeat.comBeOne Medicines Ltd. (ONC) Wins EU Nod for TevimbraJuly 25, 2025 | msn.comLai Wang Sells 700 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockJuly 23, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 700 SharesJuly 23, 2025 | insidertrades.comThe S&P 500 and Nasdaq Are Joined By These Stocks Hitting New HighsJuly 18, 2025 | msn.com Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.621.11▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼147▲ONC Articles Average Week Get the Latest News and Ratings for ONC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BeOne Medicines and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SNY News GSK News TAK News ARGX News INSM News BNTX News TEVA News SMMT News GMAB News VTRS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONC) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersNew Banking Law #1582 Could Unlock $21 Trillion for AmericansDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONC Stock Alerts